Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Arnold

Showing results (191-200 of 235) with videos related to

Pageof 24
Sort By:
International Journal of Cancer|January 27, 2017
Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancerAndreas Herbst, Nikolay Vdovin, Sanja Gacesa, et al.
Onkologie|May 18, 2011
[Gastrointestinal tumors--interdisciplinary discussion over new data]Dirk Arnold, Rainer Fietkau, Susanna Hegewisch-Becker, et al.
Cardiovascular and Interventional Radiology|September 25, 2020
Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in FranceRomaric Loffroy, Maxime Ronot, Michel Greget, et al.
Endoscopy|April 8, 2020
Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020Jeanin E van Hooft, Joyce V Veld, Dirk Arnold, et al.
Cancer Medicine|February 11, 2022
Causes of mortality in elderly UICC stage III colon cancer (CC) patients--Tumor-related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registryStefanie Nöpel-Dünnebacke, Hendrick Jütte, Robin Denz, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2020
Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trialRebekka Kosmala, Emmanouil Fokas, Michael Flentje, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 14, 2017
Metrology for decommissioning nuclear facilities: Partial outcomes of joint research project within the European Metrology Research ProgramJiri Suran, Petr Kovar, Jana Smoldasova, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2025
German S2k-guideline on diagnostics, treatment and surveillance of low-grade appendiceal mucinous neoplasms (LAMN)Franziska Köhler, Dirk Arnold, Daniela Aust, et al.
International Journal of Cancer|March 15, 2019
Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trialMarkus Diefenhardt, Ralf-Dieter Hofheinz, Daniel Martin, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapyPaul Ruff, David R Ferry, Radek Lakomỳ, et al.
Pageof 24

Showing results (191-200 of 235) with videos related to

Sort By:
Pageof 24
International Journal of Cancer|January 27, 2017
Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancerAndreas Herbst, Nikolay Vdovin, Sanja Gacesa, et al.
Onkologie|May 18, 2011
[Gastrointestinal tumors--interdisciplinary discussion over new data]Dirk Arnold, Rainer Fietkau, Susanna Hegewisch-Becker, et al.
Cardiovascular and Interventional Radiology|September 25, 2020
Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in FranceRomaric Loffroy, Maxime Ronot, Michel Greget, et al.
Endoscopy|April 8, 2020
Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020Jeanin E van Hooft, Joyce V Veld, Dirk Arnold, et al.
Cancer Medicine|February 11, 2022
Causes of mortality in elderly UICC stage III colon cancer (CC) patients--Tumor-related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registryStefanie Nöpel-Dünnebacke, Hendrick Jütte, Robin Denz, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2020
Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trialRebekka Kosmala, Emmanouil Fokas, Michael Flentje, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 14, 2017
Metrology for decommissioning nuclear facilities: Partial outcomes of joint research project within the European Metrology Research ProgramJiri Suran, Petr Kovar, Jana Smoldasova, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2025
German S2k-guideline on diagnostics, treatment and surveillance of low-grade appendiceal mucinous neoplasms (LAMN)Franziska Köhler, Dirk Arnold, Daniela Aust, et al.
International Journal of Cancer|March 15, 2019
Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trialMarkus Diefenhardt, Ralf-Dieter Hofheinz, Daniel Martin, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapyPaul Ruff, David R Ferry, Radek Lakomỳ, et al.
Pageof 24